Literature DB >> 28866430

The role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer.

Xiyin Wang1, Mircea Ivan2, Shannon M Hawkins3.   

Abstract

MicroRNA molecules are small, single-stranded RNA molecules that function to regulate networks of genes. They play important roles in normal female reproductive tract biology, as well as in the pathogenesis and progression of epithelial ovarian cancer. DROSHA, DICER, and Argonaute proteins are components of the microRNA-regulatory machinery and mediate microRNA production and function. This review discusses aberrant expression of microRNA molecules and microRNA-regulating machinery associated with clinical features of epithelial ovarian cancer. Understanding the regulation of microRNA molecule production and function may facilitate the development of novel diagnostic and therapeutic strategies to improve the prognosis of women with epithelial ovarian cancer. Additionally, understanding microRNA molecules and microRNA-regulatory machinery associations with clinical features may influence prevention and early detection efforts.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Argonaute; Dicer; Drosha; Epithelial ovarian cancer; Female reproductive tract cancer; MicroRNA molecules

Mesh:

Substances:

Year:  2017        PMID: 28866430      PMCID: PMC5741188          DOI: 10.1016/j.ygyno.2017.08.027

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  78 in total

1.  DICER1 exons 25 and 26 mutations are rare in common human tumours besides Sertoli-Leydig cell tumour.

Authors:  Min S Kim; Sung H Lee; Nam J Yoo; Sug H Lee
Journal:  Histopathology       Date:  2013-06-13       Impact factor: 5.087

2.  Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.

Authors:  Alireza Heravi-Moussavi; Michael S Anglesio; S-W Grace Cheng; Janine Senz; Winnie Yang; Leah Prentice; Anthony P Fejes; Christine Chow; Alicia Tone; Steve E Kalloger; Nancy Hamel; Andrew Roth; Gavin Ha; Adrian N C Wan; Sarah Maines-Bandiera; Clara Salamanca; Barbara Pasini; Blaise A Clarke; Anna F Lee; Cheng-Han Lee; Chengquan Zhao; Robert H Young; Samuel A Aparicio; Poul H B Sorensen; Michelle M M Woo; Niki Boyd; Steven J M Jones; Martin Hirst; Marco A Marra; Blake Gilks; Sohrab P Shah; William D Foulkes; Gregg B Morin; David G Huntsman
Journal:  N Engl J Med       Date:  2011-12-21       Impact factor: 91.245

3.  Serum microRNAs in clear cell carcinoma of the ovary.

Authors:  Angel Chao; Chyong-Huey Lai; Hua-Chien Chen; Chiao-Yun Lin; Chia-Lung Tsai; Yun-Hsin Tang; Huei-Jean Huang; Chen-Tao Lin; Min-Yu Chen; Kuang-Gen Huang; Hung-Hsueh Chou; Ting-Chang Chang; Shu-Jen Chen; Tzu-Hao Wang
Journal:  Taiwan J Obstet Gynecol       Date:  2014-12       Impact factor: 1.705

4.  Endometrioid and clear cell ovarian cancers: a comparative analysis of risk factors.

Authors:  Christina M Nagle; Catherine M Olsen; Penelope M Webb; Susan J Jordan; David C Whiteman; Adèle C Green
Journal:  Eur J Cancer       Date:  2008-08-15       Impact factor: 9.162

5.  Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer.

Authors:  Young Eun Choi; Khyati Meghani; Marie-Eve Brault; Lucas Leclerc; Yizhou J He; Tovah A Day; Kevin M Elias; Ronny Drapkin; David M Weinstock; Fanny Dao; Karin K Shih; Ursula Matulonis; Douglas A Levine; Panagiotis A Konstantinopoulos; Dipanjan Chowdhury
Journal:  Cell Rep       Date:  2016-01-07       Impact factor: 9.423

6.  Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison.

Authors:  Nicole S Spoelstra; Diana M Cittelly; Jessica L Christenson; Michael A Gordon; Anthony Elias; Paul Jedlicka; Jennifer K Richer
Journal:  Hum Pathol       Date:  2016-05-31       Impact factor: 3.466

7.  Dicer is essential for mouse development.

Authors:  Emily Bernstein; Sang Yong Kim; Michelle A Carmell; Elizabeth P Murchison; Heather Alcorn; Mamie Z Li; Alea A Mills; Stephen J Elledge; Kathryn V Anderson; Gregory J Hannon
Journal:  Nat Genet       Date:  2003-10-05       Impact factor: 38.330

8.  MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium.

Authors:  Jennifer Permuth-Wey; Zhihua Chen; Ya-Yu Tsai; Hui-Yi Lin; Y Ann Chen; Jill Barnholtz-Sloan; Michael J Birrer; Stephen J Chanock; Daniel W Cramer; Julie M Cunningham; David Fenstermacher; Brooke L Fridley; Montserrat Garcia-Closas; Simon A Gayther; Aleksandra Gentry-Maharaj; Jesus Gonzalez-Bosquet; Edwin Iversen; Heather Jim; John McLaughlin; Usha Menon; Steven A Narod; Catherine M Phelan; Susan J Ramus; Harvey Risch; Honglin Song; Rebecca Sutphen; Kathryn L Terry; Jonathan Tyrer; Robert A Vierkant; Nicolas Wentzensen; Johnathan M Lancaster; Jin Q Cheng; Andrew Berchuck; Paul D P Pharoah; Joellen M Schildkraut; Ellen L Goode; Thomas A Sellers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-06-02       Impact factor: 4.254

9.  MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma.

Authors:  Nozomu Yanaihara; Yukiko Noguchi; Misato Saito; Masataka Takenaka; Satoshi Takakura; Kyosuke Yamada; Aikou Okamoto
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

10.  Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma.

Authors:  Xinchen Zhang; Gordon Guo; Guang Wang; Jinyao Zhao; Bo Wang; Xiaotang Yu; Yanfang Ding
Journal:  Mol Med Rep       Date:  2015-10-26       Impact factor: 2.952

View more
  7 in total

1.  A Polyethylene Glycol-Based Method for Enrichment of Extracellular Vesicles from Culture Supernatant of Human Ovarian Cancer Cell Line A2780 and Body Fluids of High-Grade Serous Carcinoma Patients.

Authors:  Ruili Jiao; Shipeng Sun; Xiaoqiong Gao; Ran Cui; Guangming Cao; Huali Wei; Shuzhen Wang; Zhenyu Zhang; Huimin Bai
Journal:  Cancer Manag Res       Date:  2020-07-24       Impact factor: 3.989

2.  Pten and Dicer1 loss in the mouse uterus causes poorly differentiated endometrial adenocarcinoma.

Authors:  Xiyin Wang; Jillian R H Wendel; Robert E Emerson; Russell R Broaddus; Chad J Creighton; Douglas B Rusch; Aaron Buechlein; Francesco J DeMayo; John P Lydon; Shannon M Hawkins
Journal:  Oncogene       Date:  2020-08-25       Impact factor: 9.867

Review 3.  From the Argonauts Mythological Sailors to the Argonautes RNA-Silencing Navigators: Their Emerging Roles in Human-Cell Pathologies.

Authors:  Vasiliki I Pantazopoulou; Stella Georgiou; Panos Kakoulidis; Stavroula N Giannakopoulou; Sofia Tseleni; Dimitrios J Stravopodis; Ema Anastasiadou
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

4.  Branched rolling circle amplification method for measuring serum circulating microRNA levels for early breast cancer detection.

Authors:  Tingting Fan; Yu Mao; Qinsheng Sun; Feng Liu; Jin-Shun Lin; Yajie Liu; Junwei Cui; Yuyang Jiang
Journal:  Cancer Sci       Date:  2018-08-20       Impact factor: 6.716

5.  MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.

Authors:  Yan Zhao; Ke Ma; Shujun Yang; Xiaosan Zhang; Feng Wang; Xiaqing Zhang; Hongtao Liu; Qingxia Fan
Journal:  Int J Oncol       Date:  2018-05-16       Impact factor: 5.650

Review 6.  The Endometriotic Tumor Microenvironment in Ovarian Cancer.

Authors:  Jillian R Hufgard Wendel; Xiyin Wang; Shannon M Hawkins
Journal:  Cancers (Basel)       Date:  2018-08-07       Impact factor: 6.639

7.  MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway.

Authors:  Cuihong Li; Shunrui Yu; Shanshan Wu; Ying Ni; Zixuan Pan
Journal:  Onco Targets Ther       Date:  2019-07-08       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.